BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11184072)

  • 1. Consequences of estrogen deprivation and the rationale for hormone replacement therapy.
    Hammond CB; Rackley CE; Fiorica J; Morrison A; Wysocki S
    Am J Manag Care; 2000 Sep; 6(14 Suppl):S746-60. PubMed ID: 11184072
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone therapy and menopause].
    Heutling D; Lehnert H
    Dtsch Med Wochenschr; 2005 Apr; 130(13):829-34. PubMed ID: 15789305
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone replacement therapy: the right choice for your patient?
    Leong SL; Erickson DR; Pees RC
    J Fam Pract; 2005 May; 54(5):428-36. PubMed ID: 15865901
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
    Dick SE; DeWitt DE; Anawalt BD
    Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopause: refining benefits and risks of hormone replacement therapy.
    Cooper A; Whitehead M
    Curr Opin Obstet Gynecol; 1995 Jun; 7(3):214-9. PubMed ID: 7647275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The women's health initiative and more].
    Dören M
    Pharm Unserer Zeit; 2004; 33(5):366-71. PubMed ID: 15497331
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
    Nilsson K
    Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inconveniences and risks of untreated menopause. Benefits brought by the replacement hormonal treatment].
    Drapier-Faure E
    Rev Fr Gynecol Obstet; 1992; 87(7-9):393-6. PubMed ID: 1332177
    [No Abstract]   [Full Text] [Related]  

  • 9. Another use for estrogen? Hormone may influence Alzheimer's disease.
    Cornell S
    Adv Nurse Pract; 1997 Jun; 5(6):49-50, 53. PubMed ID: 9459928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone therapy during menopause and risk of cardiovascular disease].
    Pedersen AT; Ottesen BS
    Ugeskr Laeger; 2002 Apr; 164(18):2414. PubMed ID: 12024849
    [No Abstract]   [Full Text] [Related]  

  • 11. Current issues in hormone replacement therapy.
    Timins JK
    N J Med; 2004 Mar; 101(3):21-7. PubMed ID: 15042800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormone replacement therapy for the primary prevention of chronic condition. Recommendations and rationale. U.S. Preventive Services Task Force.
    USPSTF
    Am Fam Physician; 2003 Jan; 67(2):358-64. PubMed ID: 12562158
    [No Abstract]   [Full Text] [Related]  

  • 13. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIH-supported intervention trials in osteoporosis.
    McGowan JA
    Aging (Milano); 1998 Apr; 10(2):160. PubMed ID: 9666216
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatments for menopause].
    Lopes P
    Contracept Fertil Sex; 1998 Apr; 26(4):266-78. PubMed ID: 9622961
    [No Abstract]   [Full Text] [Related]  

  • 16. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 19. [Post-menopausal hormone replacement therapy after 70 years of age. Is it to be administered?].
    Bouillanne O; Piette F
    Rev Prat; 1998 Sep; 48(13):1398-400. PubMed ID: 10050616
    [No Abstract]   [Full Text] [Related]  

  • 20. [The story of the reversal of opinion about hormone replacement therapy and cardiovascular disease].
    Løkkegaard EC
    Ugeskr Laeger; 2005 Mar; 167(10):1166-70. PubMed ID: 15810574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.